Literature DB >> 14738840

Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

M N V Ravi Kumar1, U Bakowsky, C M Lehr.   

Abstract

Nanoparticles formulated from biodegradable polymers such as poly(lactic acid) (PLA) and poly(lactide-co-glycolide) (PLGA) are being extensively investigated as non-viral gene delivery systems due to their controlled release characteristics and biocompatibility. PLGA nanoparticles for DNA delivery are mainly formulated by an emulsion-solvent evaporation technique using PVA as a stabilizer generating negatively charged particles and heterogeneous size distribution. The objective of the present study was to formulate cationically modified PLGA nanoparticles with defined size and shape that can efficiently bind DNA. An Emulsion-diffusion-evaporation technique to make cationic nanospheres composed of biodegradable and biocompatible co-polyester PLGA has been developed. PVA-chitosan blend was used to stabilize the PLGA nanospheres. The nanospheres were characterized by atomic force microscopy (AFM), photon-correlation spectroscopy (PCS), and Fourier transform infrared spectroscopy (FTIR). Zeta potential and gel electrophoresis studies were also performed to understand the surface properties of nanospheres and their ability to condense negatively charged DNA. The designed nanospheres have a zeta potential of 10mV at pH 7.4 and size under 200nm. From the gel electrophoresis studies we found that the charge on the nanospheres is sufficient to efficiently bind the negatively charged DNA electrostatically. These cationic PLGA nanospheres could serve as potential alternatives of the existing negatively charged nanoparticles.

Mesh:

Substances:

Year:  2004        PMID: 14738840     DOI: 10.1016/j.biomaterials.2003.08.069

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  71 in total

1.  Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.

Authors:  Chunqiang Guo; Richard A Gemeinhart
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

2.  Stereological analysis of the poly-(DL-lactide-co-glycolide) submicron sphere prepared by solvent/non-solvent chemical methods and centrifugal processing.

Authors:  M Stevanovic; N Ignjatovic; B Jordovic; D Uskokovic
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 3.896

Review 3.  AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.

Authors:  Zongchao Han; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

Review 4.  Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.

Authors:  Ryan G Soderquist; Melissa J Mahoney
Journal:  Expert Opin Drug Deliv       Date:  2010-03       Impact factor: 6.648

5.  Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.

Authors:  Sathish Dyawanapelly; Uday Koli; Vimisha Dharamdasani; Ratnesh Jain; Prajakta Dandekar
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

6.  In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency.

Authors:  Azita J Mahiny; Alexander Dewerth; Lauren E Mays; Mohammed Alkhaled; Benedikt Mothes; Emad Malaeksefat; Brigitta Loretz; Jennifer Rottenberger; Darina M Brosch; Philipp Reautschnig; Pacharapan Surapolchai; Franziska Zeyer; Andrea Schams; Melanie Carevic; Martina Bakele; Matthias Griese; Matthias Schwab; Bernd Nürnberg; Sandra Beer-Hammer; Rupert Handgretinger; Dominik Hartl; Claus-Michael Lehr; Michael S D Kormann
Journal:  Nat Biotechnol       Date:  2015-05-18       Impact factor: 54.908

7.  Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin.

Authors:  Malgorzata S Cartiera; Elisa C Ferreira; Christina Caputo; Marie E Egan; Michael J Caplan; W Mark Saltzman
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 8.  Marine polysaccharides in pharmaceutical applications: an overview.

Authors:  Paola Laurienzo
Journal:  Mar Drugs       Date:  2010-09-02       Impact factor: 5.118

9.  Evaluation of mucoadhesive PLGA microparticles for nasal immunization.

Authors:  Dilip Pawar; Amit K Goyal; Sharad Mangal; Neeraj Mishra; Bhuvaneshwar Vaidya; Shailja Tiwari; Arvind K Jain; Suresh P Vyas
Journal:  AAPS J       Date:  2010-01-15       Impact factor: 4.009

10.  The evaluation of the possibilities of using PLGA co-polymer and its composites with carbon fibers or hydroxyapatite in the bone tissue regeneration process - in vitro and in vivo examinations.

Authors:  Magdalena Cieślik; Anna Mertas; Anna Morawska-Chochół; Daniel Sabat; Rajmund Orlicki; Aleksander Owczarek; Wojciech Król; Tadeusz Cieślik
Journal:  Int J Mol Sci       Date:  2009-07-15       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.